Inhibition of ShcA isoforms p46/p52Shc enhances HIV-1 replication in CD4+ T-lymphocytes

Luca Benetti1, Arianna Calistri, Cristina Ulivieri

  • 1Department of Histology, Microbiology and Medical Biotechnologies, Section of Microbiology and Virology, University of Padua, Padua, Italy.

Insights

ShcA proteins in CD4(+) T-cells are crucial for initiating apoptosis during HIV-1 infection. Inhibiting these proteins reduces cell death and increases HIV-1 particle production, revealing a key mechanism in viral pathogenesis.

Area of Science:

  • Molecular Biology
  • Immunology
  • Virology

Background:

  • HIV-1 infection leads to CD4(+) T-cell depletion, with apoptosis implicated as a key mechanism.
  • Shc proteins (ShcA, ShcB, ShcC) are involved in cellular signaling, differentiation, and stress-induced apoptosis.
  • Two ShcA splicing variants, p46Shc and p52Shc, are expressed in T-lymphocytes.

Purpose of the Study:

  • To investigate the role of ShcA proteins (p46Shc and p52Shc) in HIV-1 infection of CD4(+) T-cells.
  • To determine the impact of ShcA inhibition on HIV-1 replication and T-cell apoptosis.

Main Methods:

  • Utilized a dominant-negative mutant to inhibit p46Shc and p52Shc function in CD4(+) T-cells.
  • Quantified HIV-1 particle production and viral gene expression efficiency.
  • Assessed the percentage of CD4(+) T-cells undergoing apoptosis.

Main Results:

  • Inhibition of p46Shc and p52Shc significantly enhanced HIV-1 particle production.
  • Viral gene expression efficiency remained unaffected by ShcA inhibition.
  • A decrease in the percentage of CD4(+) T-cells entering apoptosis was observed in cells with inhibited ShcA.

Conclusions:

  • ShcA proteins play a role in mediating CD4(+) T-cell apoptosis in response to HIV-1 infection.
  • The findings suggest ShcA proteins are involved in the host's apoptotic response, potentially influencing HIV-1 pathogenesis.